James W. Plonk

424 total citations
23 papers, 310 citations indexed

About

James W. Plonk is a scholar working on Endocrinology, Diabetes and Metabolism, Epidemiology and Neurology. According to data from OpenAlex, James W. Plonk has authored 23 papers receiving a total of 310 indexed citations (citations by other indexed papers that have themselves been cited), including 16 papers in Endocrinology, Diabetes and Metabolism, 11 papers in Epidemiology and 9 papers in Neurology. Recurrent topics in James W. Plonk's work include Neuroendocrine Tumor Research Advances (11 papers), Pituitary Gland Disorders and Treatments (9 papers) and Neuroblastoma Research and Treatments (9 papers). James W. Plonk is often cited by papers focused on Neuroendocrine Tumor Research Advances (11 papers), Pituitary Gland Disorders and Treatments (9 papers) and Neuroblastoma Research and Treatments (9 papers). James W. Plonk collaborates with scholars based in United States. James W. Plonk's co-authors include Jerome M. Feldman, Harold E. Lebovitz, Stuart Handwerger, James A. Feldman, James C. Cornette and James Sidbury and has published in prestigious journals such as The Journal of Clinical Endocrinology & Metabolism, Cancer and Diabetes.

In The Last Decade

James W. Plonk

22 papers receiving 270 citations

Peers

James W. Plonk

EDM

EPIDE

NEURO

SURGE

PHYSI

L Botalla Italy

Robert C. Osburne United States

L Belforte Italy

G.F. Argenio Italy

Jackie Barley United Kingdom

Gregory I. Hockings Australia

Ermanno Rolandi Italy

N. Lytras United Kingdom

M Benmiloud Algeria

Frantz Ag Japan

L Botalla Italy

James W. Plonk

488 ×3.1

EDM

45 ×0.6

EPIDE

20 ×0.4

NEURO

92 ×1.7

SURGE

50 ×0.9

PHYSI

Citations per year, relative to James W. Plonk James W. Plonk (= 1×) peers L Botalla

Countries citing papers authored by James W. Plonk

Since Specialization

Citations

This map shows the geographic impact of James W. Plonk's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by James W. Plonk with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites James W. Plonk more than expected).

Fields of papers citing papers by James W. Plonk

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by James W. Plonk. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by James W. Plonk. The network helps show where James W. Plonk may publish in the future.

Co-authorship network of co-authors of James W. Plonk

This figure shows the co-authorship network connecting the top 25 collaborators of James W. Plonk. A scholar is included among the top collaborators of James W. Plonk based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with James W. Plonk. James W. Plonk is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Feldman, Jerome M. & James W. Plonk. (1978). Effect of Hyperprolactinemia on Pituitary-Adrenal Function. Hormone Research. 9(1). 1–11. 3 indexed citations

Feldman, Jerome M. & James W. Plonk. (1977). Pituitary-Gonadal Function in the Carcinoid Syndrome: Effect of Parachlorophenylalanine Therapy. Hormone and Metabolic Research. 9(2). 156–160. 2 indexed citations

Feldman, Jerome M., et al.. (1977). Plasma para-chlorophenylalanine measurements with gas-liquid chromatography. Biochemical Medicine. 17(3). 333–346. 3 indexed citations

Feldman, Jerome M., et al.. (1976). INHIBITORY EFFECT OF SEROTONIN ANTAGONISTS ON GROWTH HORMONE RELEASE IN ACROMEGALIC PATIENTS. Clinical Endocrinology. 5(1). 71–78. 2 indexed citations

Feldman, Jerome M. & James W. Plonk. (1976). Effect of Age on Intravenous Glucose Tolerance and Insulin Secretion*. Journal of the American Geriatrics Society. 24(1). 1–3. 11 indexed citations

Feldman, Jerome M. & James W. Plonk. (1976). Effect of intravenous glucose and insulin on plasma tryptophan and tyrosine concentrations in normal subjects and patients with carcinoid tumors. Metabolism. 25(1). 97–103. 3 indexed citations

Feldman, Jerome M., et al.. (1976). Plasma amino acids in patients with the carcinoid syndrome. Cancer. 38(5). 2127–2131. 3 indexed citations

Feldman, Jerome M., et al.. (1976). INHIBITORY EFFECT OF SEROTONIN ANTAGONISTS ON GROWTH HORMONE RELEASE IN ACROMEGALIC PATIENTS. Clinical Endocrinology. 5(1). 71–78. 12 indexed citations

Plonk, James W. & Jerome M. Feldman. (1976). Reliability of copper reduction methods for quantitation of glucosuria. Acta Diabetologica. 13(1-2). 47–53.

10.

Feldman, Jerome M., et al.. (1976). Therapeutic Doses of Cyproheptadine Do Not Inhibit Monoamine Oxidase in Man. The Journal of Clinical Pharmacology. 16(2-3). 106–109. 2 indexed citations

11.

Plonk, James W., et al.. (1976). Modification of Adrenal Function by the Anti-Serotonin Agent Cyproheptadine. The Journal of Clinical Endocrinology & Metabolism. 42(2). 291–295. 18 indexed citations

12.

Feldman, Jerome M., et al.. (1975). The Role of Cortisol and Growth Hormone in the Counter-Regulation of Insulin-Induced Hypoglycemia. Hormone and Metabolic Research. 7(5). 378–381. 18 indexed citations

13.

Handwerger, Stuart, et al.. (1975). Failure of 5-Hydroxytryptophan to Stimulate Prolactin and Growth Hormone Secretion in Man. Hormone and Metabolic Research. 7(3). 214–216. 32 indexed citations

14.

Feldman, Jerome M., et al.. (1975). Glucose Intolerance in the Carcinoid Syndrome. Diabetes. 24(7). 664–671. 17 indexed citations

15.

Plonk, James W. & Jerome M. Feldman. (1975). Adrenal function in the carcinoid syndrome: Effects of the serotonin antagonist cyproheptadine. Metabolism. 24(9). 1035–1046. 17 indexed citations

16.

Feldman, James A., James W. Plonk, & James C. Cornette. (1974). Serum prostaglandin F2α concentration in the carcinoid syndrome. Prostaglandins. 7(6). 501–506. 19 indexed citations

17.

Plonk, James W., et al.. (1974). Inhibition of Hypoglycemia-Induced Cortisol Secretion by the Serotonin Antagonist Cyproheptadine. The Journal of Clinical Endocrinology & Metabolism. 38(5). 836–840. 73 indexed citations

18.

Feldman, Jerome M., et al.. (1974). Alterations of pituitary-gonadal function in the carcinoid syndrome. The American Journal of the Medical Sciences. 268(4). 215–226. 9 indexed citations

19.

Feldman, Jerome M., et al.. (1974). Monoamine oxidase inhibition: Possible mechanism for cyproheptadine-induced alterations in insulin secretion. Life Sciences. 15(6). 1121–1134. 10 indexed citations

20.

Plonk, James W.. (1974). Carcinoid Arthropathy. Archives of Internal Medicine. 134(4). 651–651. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact